Processa Pharmaceuticals, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
The Chiliz Group Ltd. has increased its beneficial ownership in Processa Pharmaceuticals, Inc. to 13.0% through a recent share purchase.
NASDAQ
Chiliz Group Ltd. has acquired a 10.9% stake in Processa Pharmaceuticals, Inc. for approximately $1.24 million, citing a strategic investment in biotech-fintech convergence.
NASDAQ
HX Entertainment Ltd., controlled by blockchain entrepreneur Alexandre Dreyfus, has acquired a 10.9% stake in Processa Pharmaceuticals, Inc. for investment purposes, aligning with Processa's exploration of cryptocurrency treasury strategies.